| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 7206- | GBE, | EGb 761, | Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review |
| - | Review, | AD, | NA |
| 7188- | GBE, | Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial |
| - | Trial, | AD, | NA |
| 7212- | GBE, | The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 7189- | GBE, | Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx] |
| - | Trial, | NA, | NA |
| 7226- | GBE, | Ginkgo biloba exocarp extracts induces apoptosis in Lewis lung cancer cells involving MAPK signaling pathways |
| - | vitro+vivo, | Lung, | NA |
| 7223- | GBE, | Ginkgo biloba Exocarp Extract Inhibits the Metastasis of B16-F10 Melanoma Involving PI3K/Akt/NF- κ B/MMP-9 Signaling Pathway |
| - | vitro+vivo, | Melanoma, | B16-F10 |
| 7670- | GCL2505, | Effect of Continuous Ingestion of Bifidobacteria and Dietary Fiber on Improvement in Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial |
| - | Trial, | AD, | NA |
| 7130- | Ge-132, | Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer |
| - | Trial, | BC, | NA |
| 7124- | Ge-132, | Physiological Activity of Trace Element Germanium including Anticancer Properties |
| - | Review, | Var, | NA |
| 7109- | GEN, | Single- and multiple-dose pharmacokinetics of genistein capsules in healthy chinese subjects: A phase I, randomized, open-label study |
| - | Trial, | Nor, | NA |
| - | Trial, | Pca, | NA |
| 7110- | GEN, | Genistein |
| - | Review, | AD, | NA |
| 7107- | GEN, | Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients |
| - | Trial, | Pca, | NA | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | PC3 |
| 7105- | GEN, | Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer |
| - | Trial, | Pca, | NA |
| - | Trial, | Pca, | NA |
| 7102- | GEN, | Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits |
| - | Review, | Var, | NA |
| 7112- | GEO2, | Hazard assessment of germanium supplements |
| - | Review, | Var, | NA |
| 7113- | GEO2, | Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide |
| - | Review, | Nor, | NA |
| 6564- | Ger, | Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2 |
| - | in-vitro, | HCC, | HepG2 |
| 6567- | Ger, | Geraniin inhibits proliferation and induces apoptosis through inhibition of phosphatidylinositol 3-kinase/Akt pathway in human colorectal cancer in vitro and in vivo |
| - | vitro+vivo, | CRC, | SW480 | - | in-vitro, | CRC, | HT29 |
| 7201- | GGB, | Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway |
| - | vitro+vivo, | GC, | AGS | - | in-vitro, | GC, | HGC27 |
| 7276- | GGB, | Pharmacokinetics of Ginkgolide B after Oral Administration of Three Different Ginkgolide B Formulations in Beagle Dogs |
| - | in-vivo, | Nor, | NA |
| 7143- | GI, | Chemo, | Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial |
| - | Trial, | Var, | NA |
| - | Trial, | Var, | NA |
| - | Trial, | BC, | NA |
| 7136- | GI, | [6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2 |
| - | vitro+vivo, | NSCLC, | H1650 |
| 7140- | GI, | Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes |
| - | Review, | Var, | NA |
| 7139- | GI, | 6-Shogaol Exhibits a Promoting Effect with Tax via Binding HSP60 in Non-Small-Cell Lung Cancer |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Melanoma, | A375 | - | in-vitro, | GBM, | U251 |
| 7152- | GI, | Role of Ginger in management of nausea among patients receiving chemotherapy |
| - | Trial, | Var, | NA |
| 7135- | GI, | Examination of the Pharmacokinetics of Active Ingredients of Ginger in Humans |
| - | Trial, | Nor, | NA |
| 7154- | GI, | Chemo, | Effects of Ginger Intake on Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Randomized Clinical Trials |
| - | Review, | Var, | NA |
| 7155- | GI, | BSB, | Effect of Ginger and Chamomile on Nausea and Vomiting Caused by Chemotherapy in Iranian Women with Breast Cancer |
| - | Trial, | BC, | NA |
| 7138- | GI, | 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Lung, | A549 |
| 2465- | GI, | Effect of daily ginger consumption on platelet aggregation |
| - | Trial, | Nor, | NA |
| 7245- | Gink, | Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity |
| - | vitro+vivo, | Pca, | DU145 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Nor, | MCF10 |
| 7248- | Gink, | Studies on the cytotoxic mechanisms of ginkgetin in a human ovarian adenocarcinoma cell line |
| - | in-vitro, | Ovarian, | OVCAR-3 | - | in-vitro, | Cerv, | HeLa | - | NA, | NA, | OV1369 |
| 7250- | Gink, | Ginkgetin from Ginkgo biloba: mechanistic insights into anticancer efficacy |
| - | Review, | Var, | NA |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 |
| 7262- | Gink, | Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways |
| - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | SKOV3 |
| 7264- | Gink, | Anti-tumor effect of ginkgetin on human hepatocellular carcinoma cell lines by inducing cell cycle arrest and promoting cell apoptosis |
| - | vitro+vivo, | HCC, | HepG2 | - | NA, | HCC, | SK-HEP-1 |
| 7267- | Gink, | Neuroprotective Potential of Biflavone Ginkgetin: A Review |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 7258- | Gink, | Ginkgetin inhibits the growth of DU−145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity |
| - | vitro+vivo, | Pca, | DU145 | - | in-vitro, | CRC, | HCT116 |
| 7302- | GlaB, | Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma |
| - | vitro+vivo, | MB, | NA |
| 7305- | GoldNP, | Rad, | The use of gold nanoparticles to enhance radiotherapy in mice |
| - | in-vivo, | Var, | NA |
| 7304- | GoldNP, | Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine |
| 7321- | Gos, | The potential roles of gossypol as anticancer agent: advances and future directions |
| - | Review, | Var, | NA |
| 7317- | Gos, | A phase II study of AT-101 (gossypol) in chemotherapy-sensitive recurrent extensive stage small cell lung cancer (ES-SCLC) |
| - | Trial, | Lung, | NA |
| 7316- | Gos, | PacT, | carbop, | Chemo, | A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors |
| - | Trial, | Var, | NA |
| 7311- | Gos, | Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials |
| - | Review, | CLL, | NA |
| 7314- | Gos, | The BH3 mimetic (±) gossypol induces ROS-independent apoptosis and mitochondrial dysfunction in human A375 melanoma cells in vitro |
| - | in-vitro, | Melanoma, | A375 |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid